DiaMedica Therapeutics
DMAC
DMAC
25 hedge funds and large institutions have $3.93M invested in DiaMedica Therapeutics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
25
Holding in Top 10
–
Calls
$13K
Puts
–
Top Buyers
| 1 | +$85.5K | |
| 2 | +$47.4K | |
| 3 | +$16.3K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.62K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.46K |
Top Sellers
| 1 | -$39.3K | |
| 2 | -$32.9K | |
| 3 | -$19.2K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$3.43K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.63K |